Molecular Weight Marker Market Is Increasing Due To Untapped Opportunities In Asian Countries Till 2025: Grand View Research, Inc.


The global molecular weight marker market is expected to reach a value of USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by companies including biotechnology and biologics is the major factor that drives the growth during the forecast period. These markers are used by researchers and companies for various applications such as polymerase chain reaction (PCR), northern blotting, southern blotting, and molecular cloning. Thus, the increasing application of these products in R&D is expected to boost growth.

U.S. molecular weight marker market, by product, 2014 - 2025 (USD Million)

Increasing focus on molecular biology research is another major factor supporting the growth of the molecular weight marker market. Molecular biology research is important to understand interactions between the different systems of a cell, including DNA, RNA, and protein biosynthesis & regulation. Thus, these research activities are very high in developed countries and are growing at a high pace in developing countries including China and India. Hence, there is a growing demand for molecular weight marker for research activities, which is expected to fuel the growth.

Browse full research report on Molecular Weight Marker Market: www.grandviewresearch.com/industry-analysis/molecular-weight-marker-market                                                                                                                   

Further Key Findings From the Study Suggest:

  • DNA markers was the largest revenue-generating segment of the molecular weight marker market in 2016 and is also expected to showcase the fastest growth during forecast period
  • In the application segment, nucleic acid accounted for the largest share in 2016, owing to the large application of DNA markers in PCR, sequencing, northern blotting, southern blotting, and molecular cloning
  • The academic and research institutes dominated the molecular weight marker market in terms of revenue in 2016, due to the large focus on molecular biology and other related research activities
  • The North America molecular weight market is the leading regional sector and accounted for the largest revenue share in 2016, mainly due to the existence of large number of research laboratories and biotechnology companies in this region
  • The Asia Pacific market is projected to grow at a highest growth rate during the forecast period. The developing healthcare infrastructure and escalating interest on molecular research in the Asian countries such as India and China is a major factor contributing to the growth in this region
  • Some of the major players include Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd.; Merck KGaA; Agilent Technologies; QIAGEN; TAKARA BIO, INC.; Bio-Rad Laboratories, Inc.; Promega Corporation; and New England Biolabs

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology 

                                                                                                              
Grand View Research has segmented the molecular weight marker market on the basis of product, type, application, end-use, and region:

Molecular Weight Marker Product Outlook (Revenue, USD Million; 2014 - 2025)
  • DNA markers
    • Below 50 bp
    • 50 bp to 100 bp
    • 100 bp to 1 kb
    • 1 kb to 5 kb
    • Above 5 kb
  • Protein markers
    • Below 10 kDa
    • 10 k Da to 100 kDa
    • 100 k Da to 200 kDa
    • Above 200 kDa
  • RNA markers
Molecular Weight Marker Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Prestained markers
  • Unstained markers
  • Specialty markers
Molecular Weight Marker Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Nucleic acid applications
    • PCR
    • Sequencing
    • Northern blotting
    • Southern blotting
    • Molecular cloning
    • Others
  • Proteomics applications   
    • Western blotting
    • Gel extraction
    • Others
Molecular Weight Marker End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Academic and research institutes
  • Pharmaceutical and biotechnology companies
  • CROs
  • Others
Molecular Weight Marker Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-molecular-weight-marker-market 

                                                                     
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more